These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 24338950
1. Honokiol inhibits androgen receptor activity in prostate cancer cells. Hahm ER, Karlsson AI, Bonner MY, Arbiser JL, Singh SV. Prostate; 2014 Apr; 74(4):408-20. PubMed ID: 24338950 [Abstract] [Full Text] [Related]
2. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Hahm ER, Sakao K, Singh SV. Prostate; 2014 Sep; 74(12):1209-21. PubMed ID: 25043291 [Abstract] [Full Text] [Related]
3. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Hahm ER, Singh KB, Singh SV. Cell Cycle; 2016 Sep; 15(17):2309-20. PubMed ID: 27341160 [Abstract] [Full Text] [Related]
4. Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells. Stan SD, Singh SV. Clin Cancer Res; 2009 Aug 01; 15(15):4895-903. PubMed ID: 19622577 [Abstract] [Full Text] [Related]
5. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Hahm ER, Arlotti JA, Marynowski SW, Singh SV. Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560 [Abstract] [Full Text] [Related]
6. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway. Li Q, Ma Y, Liu XL, Mu L, He BC, Wu K, Sun WJ. Oncol Rep; 2020 Nov 15; 44(5):2093-2107. PubMed ID: 32901874 [Abstract] [Full Text] [Related]
7. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Subramaniam D, Ponnurangam S, Ramalingam S, Kwatra D, Dandawate P, Weir SJ, Umar S, Jensen RA, Anant S. Cells; 2021 Jun 26; 10(7):. PubMed ID: 34206989 [Abstract] [Full Text] [Related]
8. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor. Wang Y, Liu G, Tong D, Parmar H, Hasenmayer D, Yuan W, Zhang D, Jiang J. Prostate; 2015 Aug 01; 75(11):1187-96. PubMed ID: 25894097 [Abstract] [Full Text] [Related]
9. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells. Kim SH, Singh SV. Mol Cancer Ther; 2009 Jul 01; 8(7):1946-54. PubMed ID: 19584240 [Abstract] [Full Text] [Related]
10. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. Tsui KH, Chang YL, Feng TH, Hou CP, Lin YH, Yang PS, Lee BW, Juang HH. Prostate; 2018 Mar 01; 78(4):242-249. PubMed ID: 29164633 [Abstract] [Full Text] [Related]
11. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. Prostate; 2007 Apr 01; 67(5):521-35. PubMed ID: 17252539 [Abstract] [Full Text] [Related]
12. Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression. Lee YS, Jeong S, Kim KY, Yoon JS, Kim S, Yoon KS, Ha J, Kang I, Choe W. Biochem Biophys Res Commun; 2021 May 07; 552():44-51. PubMed ID: 33743348 [Abstract] [Full Text] [Related]
13. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. Yang J, Zou Y, Jiang D. Int J Mol Med; 2018 Apr 07; 41(4):1845-1854. PubMed ID: 29393336 [Abstract] [Full Text] [Related]
14. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells. Bi L, Yu Z, Wu J, Yu K, Hong G, Lu Z, Gao S. Tohoku J Exp Med; 2015 Nov 07; 237(3):163-72. PubMed ID: 26466521 [Abstract] [Full Text] [Related]
15. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Avtanski DB, Nagalingam A, Bonner MY, Arbiser JL, Saxena NK, Sharma D. Mol Oncol; 2014 May 07; 8(3):565-80. PubMed ID: 24508063 [Abstract] [Full Text] [Related]
16. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Cancer Res; 2006 Oct 15; 66(20):10064-72. PubMed ID: 17047070 [Abstract] [Full Text] [Related]
17. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Am J Surg; 2014 Dec 15; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590 [Abstract] [Full Text] [Related]
18. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Chen XR, Lu R, Dan HX, Liao G, Zhou M, Li XY, Ji N. Int J Oral Sci; 2011 Jan 15; 3(1):34-42. PubMed ID: 21449214 [Abstract] [Full Text] [Related]
19. [Both CK2 catalytic subunits involves in androgen receptor signaling in prostate cancer cells]. Yao K, Gao XY, Huang BJ, Li ZS, Zhou FJ, Li BY, Han H. Zhonghua Yi Xue Za Zhi; 2013 Nov 12; 93(42):3360-3. PubMed ID: 24418032 [Abstract] [Full Text] [Related]
20. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line. Liu C, Chen Z, Hu X, Wang L, Li C, Xue J, Zhang P, Chen W, Jiang A. Mol Med Rep; 2015 Jun 12; 11(6):4625-32. PubMed ID: 25673182 [Abstract] [Full Text] [Related] Page: [Next] [New Search]